Know Cancer

or
forgot password

Epidemiology of MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk


N/A
21 Years
N/A
Open (Enrolling)
Female
Cancer Free Women

Thank you

Trial Information

Epidemiology of MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk


Inclusion Criteria:



- age 21 years or older

- be a cancer-free pre- or postmenopausal woman

- have no prior personal history of any cancer (including DCIS, excluding nonmelanoma
skin-cancer)

- able to speak and read English because the questionnaire is only available in English

- able to provide informed consent

Exclusion Criteria:

- are pregnant at the time of MRI

- have a prior personal history of any cancer (including DCIS, excluding nonmelanoma
skin cancer)

Type of Study:

Observational

Study Design:

Observational Model: Case-Crossover, Time Perspective: Prospective

Outcome Measure:

breast cancer risk factors and background parenchymal enhancement (BPE).

Outcome Description:

A comparison of the distribution of breast cancer risk factors in women with low and high levels of BPE. The relationship between risk factors and categories of BPE (minimal/mild/moderate/marked) will be determined using ordinal logistic regression.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Jennifer Brooks, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

12-125

NCT ID:

NCT01649661

Start Date:

July 2012

Completion Date:

July 2014

Related Keywords:

  • Cancer Free Women
  • MRI
  • 12-125
  • premenopausal women
  • postmenopausal women
  • questionnaire
  • Breast Neoplasms

Name

Location
Memorial Sloan Kettering Cancer Center New York, New York  10021